Use of Remdesivir in Myasthenia gravis and COVID‐19-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Use of Remdesivir in Myasthenia gravis and COVID‐19

Published:2021-04-27 Issue:6 Volume:41 Page:546-550
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Peters Bradley J.¹^ORCID,Rabinstein Alejandro A.²,DuBrock Hilary M.³⁴

Affiliation:

1. Department of Pharmacy Mayo Clinic Rochester Minnesota USA

2. Division of Neurology Mayo Clinic Rochester Minnesota USA

3. Division of Pulmonary & Critical Care Medicine Mayo Clinic Rochester Minnesota USA

4. Division of Cardiovascular Medicine Mayo Clinic Rochester Minnesota USA

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/phar.2524

Reference25 articles.

1. Myasthenia Gravis

2. International consensus guidance for management of myasthenia gravis

3. Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic

4. Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network

5. Drugs and Myasthenia Gravis

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Remdesivir: treatment of COVID-19 in special populations;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-01-05

2. Real-world effectiveness of early remdesivir and sotrovimab in the highest-risk COVID-19 outpatients during the Omicron surge;Journal of Antimicrobial Chemotherapy;2022-08-01

3. The relationship between myasthenia gravis and COVID-19: a systematic review;The Egyptian Journal of Neurology, Psychiatry and Neurosurgery;2022-07-07

4. Clinical course and outcome of an outpatient clinic population with myasthenia gravis and COVID ‐19;Muscle & Nerve;2022-02-09

5. Characteristics, treatment, and outcomes of Myasthenia Gravis in COVID-19 patients: A systematic review;Clinical Neurology and Neurosurgery;2022-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3